Vivitrol 380 MG vial-diluents
Ended Awarded Last action
- Contract number
- SPE2DR26FN1L6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $31,861
Award facts
- Contract value 100% obligated
- $31,860.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $31,860.95 delivery order to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vial-diluents, with an ultimate completion date of February 2, 2026. This non-set-aside contract was awarded on a firm fixed-price basis and represents a task order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The place of performance is located in Conshohocken, PA 19428.
This delivery order is part of AmerisourceBergen's comprehensive pharmaceutical support for the Defense Health Agency and other federal healthcare systems. Vivitrol, an opioid antagonist medication used in addiction treatment, represents the type of specialized pharmaceutical commodity that falls within the company's extensive portfolio of brand-name and generic medications supplied through its prime vendor agreement with the DLA. AmerisourceBergen's parent company, Cencora, Inc., maintains the overarching IDC relationship with DLA, enabling efficient fulfillment of diverse medical supply needs across military treatment facilities and government healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DR26FN1L6?
SPE2DR26FN1L6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26FN1L6 worth?
The government has obligated $31,861 on SPE2DR26FN1L6.
Is contract SPE2DR26FN1L6 an order under another contract?
Yes. SPE2DR26FN1L6 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FN1L6 competed?
The extent of competition for SPE2DR26FN1L6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award